A Propensity Score-Weighted Comparison of Vedolizumab, Adalimumab, and Golimumab in Patients with Ulcerative Colitis: Real-Life Data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD)

Fabio Salvatore Macaluso  1     Marco Ventimiglia  1     Walter Fries  2     Maria Cappello  3     Barbara Scrivo  4     Antonio Magnano     Dario Pluchino     Salvatore Camilleri     Serena Garufi     Roberto Di Mitri     Filippo Mocciaro     Giovanni Magri     Concetta Ferracane     Michele Citrano     Francesco Graziano     Carmelo Bertolami     Sara Renna     Rosalba Orlando     Giulia    
1 'Villa Sofia-Cervello' Hospital,Palermo (Pa),Italy
2 Inflammatory Bowel Disease Unit, A.O.U. Policlinico 'G. Martinoā€¯,Messina,Italy
3 UOC Gastroenterologia ed Epatologia Di.Bi.Mis - University of Palermo,Palermo,Italy
4 UOC Gastroenterologia ed Epatologia Di.Bi.Mis - University of Palerm

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing